Systemic antimycotic and antifungal use in eastern Europe: a cross-national database study in coordination with the WHO Regional Office for Europe

Affiliations

• ¹ Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium Centre for General Practice, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium niels.adriaenssens@uantwerpen.be.
• ² Department of Pharmacy, Faculty of Medicine, University of Prishtina, Prishtina, Kosovo.
• ³ Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
• ⁴ Health Technologies and Pharmaceuticals, Division of Health Systems and Public Health, WHO Regional Office for Europe, Copenhagen, Denmark.
• ⁵ Scientific Centre of Drug and Medical Technology Expertise of the Ministry of Health, Yerevan, Armenia.
• ⁶ Ministry of Health of Azerbaijan Republic, Analytical Expertise Centre for Medicines, Baku, Azerbaijan.
• ⁷ Department on Organization of Medicines Provision, Ministry of Health, Minsk, Republic of Belarus.
• ⁸ Agency for Medicines and Medical Devices of Bosnia and Herzegovina, Banja Luka, Bosnia and Herzegovina.
• ⁹ JSC 'My Family Clinic', Tbilisi, Georgia.
• ¹⁰ CitiHope International, Bishkek, Kyrgyzstan.
• ¹¹ Agency for Medicines and Medical Devices of Montenegro, Podgorica, Montenegro.
• ¹² Agency of Medicines, Chisinau, Republic of Moldova.
• ¹³ Medicines and Medical Devices Agency of Serbia, Belgrade, Serbia.
• ¹⁴ Avicenna Tajik State Medical University, Dushanbe, Tajikistan.
• ¹⁵ Ministry of Health of Turkey, Turkish Medicines and Medical Devices Agency, Ankara, Turkey.
• ¹⁶ Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium Centre for General Practice, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.